NCT04994912View on ClinicalTrials.gov

First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

January 7, 2025

Study Completion Date

February 18, 2025

Conditions
Healthy
Interventions
DRUG

EI-001

EI-001 IV infusion

OTHER

Placebo

Placebo IV infusion

Trial Locations (2)

3004

Nucleus Network Pty Ltd, Melbourne

Unknown

Huashan Hospital of Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Elixiron Immunotherapeutics (Hong Kong) Ltd.

INDUSTRY

NCT04994912 - First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers | Biotech Hunter | Biotech Hunter